Primary Pulmonary Synovial Sarcoma Showing a Prolonged Survival with Multimodality Therapy

Intern Med. 2016;55(4):381-7. doi: 10.2169/internalmedicine.55.5169. Epub 2016 Feb 15.

Abstract

A 54-year-old man was referred to our hospital due to a mass shadow noted on a chest X-ray. Thoracoscopic lobectomy yielded a diagnosis of primary pulmonary synovial sarcoma according to the histology and SYT-SSX1 gene analyses. Five months after the thoracic surgery, he developed brain metastasis; therefore, we performed resection of the brain metastatic focus followed by radiotherapy. As a local recurrence in the thoracic cavity concurrently emerged, systemic chemotherapy was also administered. These observations indicated that a multidisciplinary approach may be useful against primary pulmonary synovial sarcoma, although there is presently no established therapeutic strategy due to its rarity and highly aggressive nature.

Publication types

  • Case Reports

MeSH terms

  • Brain Neoplasms / genetics
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / therapy*
  • Combined Modality Therapy / methods*
  • DNA, Neoplasm
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / therapy*
  • Oncogene Proteins, Fusion / genetics
  • Sarcoma, Synovial / genetics
  • Sarcoma, Synovial / pathology*
  • Sarcoma, Synovial / therapy
  • Thoracic Surgical Procedures / methods*
  • Treatment Outcome

Substances

  • DNA, Neoplasm
  • Oncogene Proteins, Fusion
  • SYT-SSX fusion protein